FDA's GMP committee
This article was originally published in The Gray Sheet
Executive SummaryAgency requests nominations for voting members on its Device Good Manufacturing Practice Advisory Committee. Two vacancies are available immediately, three will be available June 1, 1995. The committee is searching for one industry and one government representative to fill the immediate vacancies. Vacancies for a general public representative, a health professional, and a government representative will occur next June. Contact Sharon Kalokerinos at (301) 594-4613 for information regarding health professionals, industry representatives, and government representatives. For information regarding general public representatives contact Susan Meadows at (301) 443-5006
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a clinician-administered product with an addressable market of 6 million.